Evidence map›Paper›PMID 41152183›Full record

ReviewSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2025

[Application of nanomaterials-enhanced magnetic resonance imaging in precise diagnosis of pan-vascular diseases].

Yao Li, Peisen Zhang, Ni Zhang

Abstract readReviewEnglish Abstract
In one paragraph

Review in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yao LiCollege of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao, Shandong 266042, P. R. China.
Peisen ZhangCollege of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao, Shandong 266042, P. R. China.
Ni ZhangWest China Hospital of Sichuan University, Chengdu 610041, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pan-vascular diseases encompass a range of systemic conditions characterized by sharing a common pathologic basis of vascular deterioration. Due to the complexity of these diseases, a thorough understanding on their similarities and differences is essential for optimizing diagnosis and treatment strategies. Magnetic resonance imaging (MRI), as one of the commonly used medical imaging techniques, has been widely applied in the diagnosis of pan-vascular diseases. Particularly, the integration of MRI with contrast agents and multi-parameter imaging techniques significantly enhances diagnostic accuracy, reducing the likelihood of missed or incorrect diagnoses. Recently, a variety of nano-magnetic resonance contrast agents have been developed and applied to the magnetic resonance imaging diagnosis of diseases. These nanotechnology-based contrast agents provide multiple advantages, ensuring more precise and forward-looking imaging of pan-vascular conditions. In this review, the diverse application strategies of nanomaterials-enhanced MRI techniques in the diagnosis of pan-vascular diseases were systematically summarized, by classifying them into the commonly used MRI sequences in clinical practice. Additionally, the potential advantages and challenges associated with the clinical translation of nanomaterial-enhanced MRI were also discussed. This review not only offers a novel perspective on the precise diagnosis of pan-vascular diseases, but also serves as a valuable reference for future clinical practice and research in the field.

Indexed as

Contrast MediaMagnetic Resonance ImagingNanostructuresVascular DiseasesHumansContrast MediaMagnetic resonance imagingNanomaterialsPan-vascular diseases

Identifiers

PMID41152183
PMCPMC12568722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.